Related posts
3 Promising Oversold Stocks3 Promising Euro Stocks to Buy3 Bargain Stocks: Eli Lilly, Unilever & AppleThis summary was created by AI, based on 1 opinions in the last 12 months.
Experts are generally optimistic about Unilever NV with a positive outlook for the business, despite tough times due to inflation. They recommend investors to be patient as they expect positive changes with new activist investors and see opportunity for growth in emerging markets.
Lots of activist pressure. Big and bulky, not growing in line with peers. Needs to improve efficiencies to boost profitability, possibly by breaking up or selling off divisions. Potential for earnings growth and multiple expansion, but you have to be patient. His preference on valuation.
Owns shares in the company.
Consumer stable business.
Large exposure to emerging markets.
Consumer packaged business expected to grow.
Inflation forcing company to increase prices.
Long term is a good investment.
~3.5% dividend yield.
New management later this year.
Unilever NV is a American stock, trading under the symbol UN-N on the New York Stock Exchange (UN). It is usually referred to as NYSE:UN or UN-N
In the last year, 1 stock analyst published opinions about UN-N. 0 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Unilever NV.
Unilever NV was recommended as a Top Pick by on . Read the latest stock experts ratings for Unilever NV.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Unilever NV In the last year. It is a trending stock that is worth watching.
On 2020-11-27, Unilever NV (UN-N) stock closed at a price of $60.5.
Owns shares in company and likes prospects of business. Under performance of company not a concern. Emerging markets will present opportunity for growth. Inflation has made for tough times on the bottom line. Would recommend investors to be patient. Expecting positive changes in company with new activist investors.